Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Diabetes, Obesity & Metabolism|January 18, 2017
Effect of valsartan on kidney outcomes in people with impaired glucose toleranceGemma Currie, M Angelyn Bethel, Björn Holzhauer, et al.
Diabetes|May 27, 2004
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucoseAndreas Festa, Ralph D'Agostino, Anthony J G Hanley, et al.
Diabetes Care|October 8, 2009
Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis StudyCarlos Lorenzo, Lynne E Wagenknecht, Ralph B D'Agostino, et al.
Diabetes Care|June 25, 2010
A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS)Carlos Lorenzo, Lynne E Wagenknecht, Anthony J G Hanley, et al.
Diabetes Care|July 27, 2011
Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis studyCarlos Lorenzo, Lynne E Wagenknecht, Andrew J Karter, et al.
American Heart Journal|October 24, 2008
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) TrialRobert M Califf, Mitradev Boolell, Steven M Haffner, et al.
Diabetes Care|June 29, 2005
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes studyMonica Nannipieri, Clicerio Gonzales, Simona Baldi, et al.
Diabetes Care|June 28, 2002
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetesFrank B Hu, Meir J Stampfer, Steven M Haffner, et al.
Diabetes|July 29, 2003
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring StudiesJames B Meigs, Peter W F Wilson, David M Nathan, et al.
Obesity (Silver Spring, Md.)|April 11, 2009
INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family StudyMatthew E Talbert, Carl D Langefeld, Julie T Ziegler, et al.
Pageof 20